Carlsmed Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance

Carlsmed reported that third-quarter 2026 revenue increased 65% year over year, citing execution of its strategy and growth in its surgeon user base. The company raised its full-year 2026 revenue guidance. It continues to focus on AI-enabled personalized spine surgery solutions, including its aprevo platform.